JIL Sovereign
JIL Sovereign Technologies, Inc.
A Delaware Corporation · jilsovereign.com

HIPAA Security Rule Risk Assessment

Executive Summary - Public Edition
Reporting Period: May 1, 2025 to April 30, 2026
Performed by: Office of the Chief Information Security Officer
Methodology: NIST SP 800-30 Rev. 1, scoped to the controls of the HIPAA Security Rule at 45 C.F.R. Part 164, Subpart C
Full report: Released to assessors and customers under non-disclosure agreement.

1. Scope of Analysis

The risk analysis required by 45 C.F.R. § 164.308(a)(1)(ii)(A) was conducted across all production information systems of the Company that may create, receive, maintain, or transmit Electronic Protected Health Information ("ePHI") on behalf of Covered Entity customers. In-scope systems include the Company's AWS production accounts (account 884135110852 commercial; the federal-track GovCloud account is reviewed separately), the customer-facing portals at retail.jilsovereign.com and admin.jilsovereign.com, the AVA™ Pro and AVA™ Pro+ analytical pipeline, the Bedrock and SageMaker inference paths, and all supporting databases, queues, and audit ledgers.

2. Reasonably Anticipated Threats

The Company identified and evaluated the following threat categories:

  1. External adversary: credential-stuffing, exploitation of unpatched vulnerabilities, supply-chain compromise of dependencies, ransomware against application data.
  2. Insider risk: malicious or accidental misuse of authorized access by personnel or subcontractors.
  3. Subprocessor compromise: compromise of an authorized subprocessor (principally AWS) that could expose ePHI.
  4. Operational error: misconfiguration leading to public exposure of an otherwise-protected resource; data loss from inadequate backup.
  5. Natural and environmental: regional outage of cloud infrastructure; environmental disaster affecting data centers.
  6. Legal and regulatory: lawful demand for ePHI without sufficient process; conflicting legal obligations across jurisdictions.

3. Vulnerabilities Identified and Treatment

The Company maintains an active risk register in which each identified vulnerability is rated for likelihood and impact, assigned an owner, and tracked through treatment. Treatment categories used:

The current register contains residual risks rated High, Medium, or Low. No residual risks rated Critical are open at the date of this Summary.

DomainOpen RisksTop Treatment Action
Encryption and Key Management0 High, 1 MediumCloudHSM rotation procedure documented; quarterly rotation rehearsal scheduled.
Identity and Access0 High, 0 MediumWebAuthn enforced for all privileged paths; just-in-time elevation required for operator-to-PHI access.
Audit Logging0 High, 0 MediumS3 Object Lock Compliance mode in place; CourtChain™ anchoring in place; quarterly integrity verification.
Network0 High, 1 MediumPrivate subnet posture in place; pending hardening: cross-region VPC peering with stricter route table.
Vulnerability Management0 High, 2 MediumSnyk in CI; AWS Inspector weekly; pending: SBOM generation per release.
Subprocessor Risk0 High, 0 MediumAWS BAA executed; annual AWS audit-report review.
Continuity0 High, 1 MediumMulti-region failover tested; pending: cold-region disaster-recovery rehearsal.
Personnel0 High, 1 MediumSecurity training program codified; pending: role-specific incident-response training for engineering on-call.

4. Required Implementation Specifications - Status

The Security Rule administrative, physical, and technical safeguards have been mapped to the Company's controls. All Required Implementation Specifications are met. All Addressable Implementation Specifications are either met as written or addressed by an equivalent compensating control documented in the internal control mapping.

5. Reassessment Cadence

This risk analysis is performed at least annually, and additionally upon any of the following triggers:

6. Conclusion

Based on the foregoing, the Company has implemented administrative, physical, and technical safeguards that reasonably and appropriately protect the confidentiality, integrity, and availability of ePHI as required by the HIPAA Security Rule. Residual risks are documented, owned, and tracked through the Company's risk management program.